SLC2A10 antibody (AA 288-335) (Alexa Fluor 555)

Catalog No. ABIN899081

Product Details anti-SLC2A10 Antibody (Alexa Fluor 555)

Target: SLC2A10 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 10 (SLC2A10))

Binding Specificity: AA 288-335

Reactivity: Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SLC2A10 antibody is conjugated to Alexa Fluor 555

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Cross-Reactivity: Rat

Predicted Reactivity: Human,Mouse,Dog,Cow

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human GLUT10

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for SLC2A10

Target: SLC2A10 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 10 (SLC2A10))

Alternative Name: GLUT10 (SLC2A10 Products)

Synonyms: SLC2A10 antibody, zgc:171488 antibody, ATS antibody, GLUT10 antibody, AA450473 antibody, Glut10 antibody, solute carrier family 2 member 10 antibody, solute carrier family 2 (facilitated glucose transporter), member 10 antibody, SLC2A10 antibody, slc2a10 antibody, Slc2a10 antibody

Background:

Synonyms: ATS, GLUT10, Solute carrier family 2, facilitated glucose transporter member 10, Glucose transporter type 10, GLUT-10, SLC2A10

Background: Defects in SLC2A10 are the cause of arterial tortuosity syndrome (ATS) [MIM:208050]. ATS is an autosomal recessive disorder characterized by tortuosity and elongation of major arteries, often resulting in death at young age. Other typical features include aneurysms of large arteries and stenosis of the pulmonary artery, in association with facial features and several connective tissue manifestations such as soft skin and joint laxity. Histopathological findings include fragmentation of elastic fibers in the tunica media of large arteries.

Gene ID: 81031

UniProt: O95528